Evidence map›Paper›PMID 32926355›Full record

ArticleInternal and emergency medicine2021

Progressive and atypical neurological symptoms in refractory systemic AL amyloidosis.

Federico Perfetto, Silvia Casagrande, Alessandro Barilaro, Massimo Di Gioia, Raffaella Santi, Marco Allinovi, Stefano Romoli, Andrea Boschi, Ilaria Desideri, Giulia Taborchi and 2 more

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Internal and emergency medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Federico PerfettoTuscan Regional Amyloid Center, Careggi University Hospital, Florence, Italy.
Silvia CasagrandeDepartment of Neurosciences, Psychology, Pharmacology and Child Health, University of Florence, Largo Brambilla 3, 50134, Florence, Italy. silvia.casagrande@unifi.it.ORCID http://orcid.org/0000-0002-4111-1810
Alessandro BarilaroDepartment of Neurosciences, Psychology, Pharmacology and Child Health, University of Florence, Largo Brambilla 3, 50134, Florence, Italy.
Massimo Di GioiaTuscan Regional Amyloid Center, Careggi University Hospital, Florence, Italy.
Raffaella SantiPathological Anatomy Unit, Careggi University Hospital, Florence, Italy.
Marco AllinoviTuscan Regional Amyloid Center, Careggi University Hospital, Florence, Italy.
Stefano RomoliUnit of Spine Surgery, Careggi University Hospital, Florence, Italy.
Andrea BoschiUnit of Spine Surgery, Careggi University Hospital, Florence, Italy.
Ilaria DesideriNeuroradiology Unit, Careggi University Hospital, Florence, Italy.
Giulia TaborchiTuscan Regional Amyloid Center, Careggi University Hospital, Florence, Italy.
Andrea UngarSyncope Unit, Geriatric Intensive Care Medicine, Hypertension Centre, Careggi University Hospital, University of Florence, Florence, Italy.
Francesco CappelliTuscan Regional Amyloid Center, Careggi University Hospital, Florence, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AgedAmyloidosisClinical ReasoningHumansImmunoglobulin Light-chain AmyloidosisItalyMaleOutcome Assessment, Health CareShoulderTreatment Failure

Identifiers

PMID32926355

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.